Trial · NCT02593370
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Block success | Estimated 40 min after completed intervention. Presented 10 months after last patient last visit (LVLP). | Block success of the clinical relevant lumbosacral nerves that innervate the hip joint capsule estimated as significant motor block of the obturator nerve, the femoral nerve, and the lumbosacral trunk. Motor block is a significant proxy marker of sensory block. Motor block (muscle strength, mmHg) is assessed with a handheld dynamometer. |
| Secondary | Plasma lidocaine | Blood samples are withdrawn 0, 5, 10, 20, 40, 60, and 90 minutes after intervention. Presented 10 months after LVLP | |
| Secondary | Time for preparation | Estimated prior to intervention. Presented 10 months after LVLP | Time for preparation in seconds is defined as the time of placement of the volunteer on the bed until the end of pre-ultrasound scanning |
| Secondary | Block procedure time | Estimated during intervention. Presented 10 months after LVLP | Block procedure time in seconds is defined as the time of the placement of the ultrasound probe on the skin to until the block needle is pulled out after injection of local anesthetics |
| Secondary | Injection site | Estimated at the end of the intervention. Presented 10 months after LVLP | |
| Secondary | Block needle depth | Estimated at the end of the intervention. Presented 10 months after LVLP | |
| Secondary | Discomfort | Estimated immediately after the intervention. Presented 10 months after LVLP | Estimated on numeric rating scale 0-10 |
| Secondary | Mean arterial pressure change | Mean arterial pressure is measured prior intervention and 5 min after intervention. Presented 10 months after LVLP | |
| Secondary | Sensory (cold, warm, touch, pain) block of the dermatomes T12-S3 and the lateral femoral cutaneous nerve | Estimated 50 min after intervention. Presented 10 months after LVLP | |
| Secondary | Perineural spread of local anesthetics added gadoterate meglumine | Estimated on MRI sampled 10-30 minutes after intervention. Presented 10 months after LVLP | |
| Secondary | Epidural spread of local anesthetics added gadoterate meglumine | Estimated on MRI sampled 10-30 minutes after intervention. Presented 10 months after LVLP | |
| Secondary | Cost-effectiveness (ICER) | Calculated after LVLP. Presented 10 months after the last visit of the last volunteer | ICER is estimated as the difference in mean marginal cost of the blocks. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02593370/registered